Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$20.45 0.48 (2.40%)
2/9/2010 4:00 PM

Meridian Bioscience, Inc. (VIVO)

CAPS Rating:
*****

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating VIVO

Add Stock to Watchlist

What the Community Thinks

Total Members

469 Outperforms
11 Underperforms
 

All-Stars

108 Outperforms
2 Underperforms
 

Wall Street

5 Outperforms
0 Underperforms
 

Members bullish on VIVO are also bullish on:

Members bearish on VIVO are also bearish on:

Ticker Tags

Growth (1902), Defensive (1457), Income (1401), Healthcare Equipment and Supplies (176), Dividend (191), Healthcare (711), Small Cap (1645), Ohio (84)
Suggest a tag

Meridian Bioscience, Inc. At A Glance

Current Price: $20.45
Last Trade Time: 2/9/2010 4:00 PM
Open: $20.06
Previous Close: $19.97
Daily Range: $19.92 - $20.56
52-Week Range: $14.79 - $26.20
Volume: 291,880
Market Cap: $829.68M
P/E Ratio: 24.06
Compare Our Special Broker Offers!

Stock Trends

VIVO VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

2

Meridian Bioscience, Inc. (VIVO)

Avatar DODEA (53.63) Submitted: 12/29/08 11:53 AM

Meridian Biosciences has been a great pick for me since 1989. It was one of the very first stocks I owned, and my second DRIP. It has very strong financials, an intelligent business plan, and many products in its pipeline. This is an excellent small-cap stock for getting in on the ground floor.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 61 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (VIVO)

Avatar KnockoutMouse (23.83) Submitted: 12/03/09 8:02 AM : Outperform Start Price: $20.79 VIVO Score: 2.23

Meridian Bio has a return on investment above 20%, pays a nice dividend, has a solid history of revenue growth and great future prospects since diagnostics will greatly benefit under health care reform.
For some strange reason it is trading under its 50 and 200 day moving average. Going to pick this as an ugly duckling.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VIVO)

Avatar Relic666 (66.59) Submitted: 11/17/09 7:54 AM : Underperform Start Price: $22.11 VIVO Score: 4.16

With the upcoming vote on the "health reform plan", anybody that has anything to do with the health industries will suffer.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VIVO)

Avatar geomanpa (< 20) Submitted: 8/24/09 9:59 PM : Outperform Start Price: $23.61 VIVO Score: -17.64

Awesome management

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VIVO)

Avatar jemsa (88.30) Submitted: 8/20/09 3:34 PM : Outperform Start Price: $23.21 VIVO Score: -18.52

stockscouter 10, caps 5

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VIVO)

Avatar vgaymer (66.10) Submitted: 4/12/09 4:55 PM : Outperform Start Price: $17.04 VIVO Score: -7.57

msn screen:

5 year div. growth >= 20 %
annual eps growth >= 25%
debt/eq <= 0.5
current dividend >= 2.5%

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 61 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLazardCapit < 20 10/14/08 Outperform NS $25.25-19.00%+5.06%-24.06
TrackCLKing < 20 05/13/08 Outperform NS $27.15-24.67%-20.80%-3.87
TrackJimCramer < 20 09/14/07 Outperform 3W $25.91-21.07%-24.20%+3.13
TrackScottBleier 91.98 08/17/07 Outperform 3M $23.52-13.06%-22.00%+8.94
TrackHilliard 76.32 08/17/06 Outperform NS $13.95+46.61%-11.14%+57.75

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 625ms